Allogeneic γδ T Cell Therapy for the Treatment of Solid Tumors

Clinical trial NCT04765462 · UNKNOWN

Trial details

NCT number: NCT04765462
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Solid Tumours

Start date: 2021-03-01
Primary completion: 2023-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.